1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.
CAS No. 31616-94-1
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.; Cyclo(L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl)
8-(ethenylsulfanyl)quinoline hydrochloride
60157-59-7
4-(1-Adamantyl)pyridine
60159-38-8
VALINE-P-NITROBENZYL ESTER HBR
6015-79-8
1,1,1,3,9,11,11,11-OCTACHLOROUNDECANE
601523-25-5
Aluminum oxide (Al2O3)
60157-57-5
Propionitrile, 3-(methylnitrosamino).
60153-49-3
4-Isoxazolemethanol, 5-ethyl-3-methyl-
60148-44-9
2-Heptenoic acid, 2,6-dimethyl-, (E)-
60148-90-5
2-1H-PYRIDINONE,6-ETHYL-4-METHYL-1-BENZYL-
601521-95-3
(naphthalen-1-yloxy)acetaldehyde
60148-34-7
D,L-2,6-DIMETHYLHEPTANOIC ACID
60148-94-9
2-Dodecenoic acid, 3,7,11-trimethyl-, (2Z)-
60149-02-2
1-Propene, 3-[(2-chloroethyl)thio]-2-methyl-
60154-80-5
GSK-3BETA INHIBITOR XII
601514-19-6
L-Phenylalanine, (2E)-2-butenedioate (1:1)
601521-17-9
MINIMALE LIEFERMENGE
6014-81-9
PYRIMIDINE,4-(2-BUTYNYLOXY)-6-(1-METHYLPROPOXY)-
601482-63-7